Procept Biorobotics Corp specialises in surgical robotics, leading the charge in developing and commercialising autonomous robotic systems for use in minimally invasive procedures. Its operations span several continents, offering innovative solutions to healthcare institutions worldwide.
Working in the competitive sector of health technology, Procept Biorobotics Corp provides a unique service through its flagship product, the Aquabeam Robotic System, which enables effortless surgical procedures using Aquablation therapy. Procept Biorobotics designs systems for patients and urologists as a better way to treat urinary tract symptoms caused by BPH.
Monitor the PRCT share price by adding it to your eToro watchlist.